7a,12a-Dihydroxy-cholestene-3-one (BioCAD00000020109)
{$topic}
Metabolite Card
Formula: C27H44O3 (416.329)
SMILES: [H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])[C@H](O)CC2CC(=O)C=C[C@]12C
Synonyms [en]
7alpha,12alpha-Dihydroxy-cholestene-3-one; 7-a,12-a-Dihydroxycholest-4-en-3-one; 12a-Dihydroxy-cholestene-3-one; 7-a,12-alpha-Dihydroxycholest-4-en-3-one; 7-a,12-alpha-Dihydroxy-4-cholesten-3-one; (7~{R},8~{R},9~{S},10~{R},12~{S},13~{R},14~{S},17~{R})-17-[(1~{R})-1,5-dimethylhexyl]-7,12-dihydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Last reviewed on 2024-06-28.
Cite this Page
7a,12a-Dihydroxy-cholestene-3-one. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000020109). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
7a,12a-Dihydroxy-cholestene-3-one is an intermediate in bile acid synthesis; is considerably higher in patients with cerebrotendinous xanthomatosis (CTX) than in the normal liver. (PMID 7017048).
DBLinks
- CAS Registry Number:
- PubChem CID: 21252277
- ChEBI: 28477
- HMDB: HMDB0002197
- LipidMaps:
- KEGG: C05457
- BioCyc:
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- PubChem: 21252277
- ChEBI: ChEBI:28477
- HMDB: HMDB0002197
- KEGG: C05457
- Coconut NaturalProduct: CNP0365041.1
Class / Ontology
- WishartLab ClassyFire: [Cholestane steroids] Cholestane steroids
- Coconut NaturalProduct: [Cholestane steroids] Cholestane steroids
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| WikiPathways:WP3604 | Biochemical pathways: part I |
| PathBank:SMP0120468 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0000318 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120697 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0120463 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120467 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120495 | Zellweger Syndrome |
| PathBank:SMP0000035 | Bile Acid Biosynthesis |
| PathBank:SMP0000314 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0000315 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0087329 | Bile Acid Biosynthesis |
| PathBank:SMP0120652 | 27-Hydroxylase Deficiency |
| PathBank:SMP0120688 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120477 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0000317 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0087236 | Bile Acid Biosynthesis |
| PathBank:SMP0120683 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120687 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120715 | Zellweger Syndrome |
| PathBank:SMP0120871 | 27-Hydroxylase Deficiency |